Pharmacia Removes PCBs Lawsuit, Says Compounds Were Made under Direction of U.S. Government



DOCUMENTS
  • Removal Notice


ST. LOUIS –– Defendants named in a PCBs exposure suit have removed the case, saying that the production of the allegedly harmful compound took place under the direction of the U.S. Government.

In the April 13 removal notice filed in the U.S. District Court for the Eastern District of Missouri, the defendants said that Pharmacia worked “in close collaboration with the federal government regarding the production of PCBs for the U.S. military.”

Plaintiff Kathleen R. Olson filed the underlying complaint, contending that she developed non-Hodgkin’s lymphoma, malignant melanoma, or breast cancer as a result of exposure to polychlorinated biphenyls (PCBs) …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference

December 04, 2024 - New York, NY
Virgin Hotels NYC

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS